TBIO(Delisted)
Telesis BioยทNASDAQ
--
--(--)
TBIO Profile
Telesis Bio Inc.
messenger RNA or mRNA therapy company
10431 Wateridge Circle, Suite 150, San Diego, CA, 92121
--
Telesis Bio Inc., incorporated in Delaware on March 24, 2011 as Synthetic Genomics Solutions, Inc., is a wholly-owned subsidiary of Synthetic Genomics, Inc. On February 26, 2013, the company changed its name to SGI-DNA, Inc., and on March 31, 2020, it changed its name to Codex DNA, Inc. Telesis Bio empowers scientists to create novel, synthetic biology-enabled solutions to many of humanity's greatest challenges. As the inventor of the industry-standard Gibson Assembly method and the first commercially automated desktop DNA and mRNA synthesis system, Telesis Bio is enabling fast, accurate and reproducible writing of DNA and mRNA for numerous downstream markets. The award-winning BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Therefore, DNA and RNA synthesis with little error is available on a large scale in days and hours rather than weeks or months. Scientists around the world are using this technology in the laboratory to accelerate the design-build-test paradigm of new, high-value products for precision medicine, biologic drug discovery, vaccine and treatment development, genome editing, and cell and gene therapy.
